Latest & greatest articles for myocardial infarction

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on myocardial infarction or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on myocardial infarction and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for myocardial infarction

102. Intensive Care Unit Utilization Among Medicare Patients Hospitalized with Non-ST-Segment Elevation Myocardial Infarction

Intensive Care Unit Utilization Among Medicare Patients Hospitalized with Non-ST-Segment Elevation Myocardial Infarction 27806171 2018 11 13 2380-6591 2 1 2017 Jan 01 JAMA cardiology JAMA Cardiol Intensive Care Unit Utilization and Mortality Among Medicare Patients Hospitalized With Non-ST-Segment Elevation Myocardial Infarction. 36-44 10.1001/jamacardio.2016.3855 Intensive care unit (ICU) utilization may have important implications for the care and outcomes of patients with non-ST-segment (...) elevation myocardial infarction (NSTEMI). To examine interhospital variation in ICU utilization in the United States for older adults with hemodynamically stable NSTEMI and outcomes associated with ICU utilization among patients with low, moderate, or high mortality risk. This study was a retrospective analysis of 28 018 Medicare patients 65 years or older admitted with NSTEMI to 346 hospitals participating in the Acute Coronary Treatment and Intervention Outcomes Network (ACTION)-Get

JAMA cardiology2017 Full Text: Link to full Text with Trip Pro

103. Evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T1

Evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T1 Evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T1 | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T1 Article Text

Evidence-Based Medicine (Requires free registration)2017

104. Early invasive strategy should be performed within 72 hours in high-risk patients with non-ST-elevation myocardial infarction

Early invasive strategy should be performed within 72 hours in high-risk patients with non-ST-elevation myocardial infarction Early invasive strategy should be performed within 72 hours in high-risk patients with non-ST-elevation myocardial infarction | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Early invasive strategy should be performed within 72 hours in high-risk patients with non-ST-elevation myocardial infarction Article Text

Evidence-Based Medicine (Requires free registration)2017

105. Acute myocardial infarction can be ruled out with a single high-sensitivity cardiac troponin T level

Acute myocardial infarction can be ruled out with a single high-sensitivity cardiac troponin T level Acute myocardial infarction can be ruled out with a single high-sensitivity cardiac troponin T level | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Acute myocardial infarction can be ruled out with a single high-sensitivity cardiac troponin T level Article Text Commentary: Emergency care Acute myocardial infarction can be ruled out

Evidence-Based Medicine (Requires free registration)2017

106. Stent choice in cardiogenic shock complicating acute myocardial infarction likely does not affect mortality or reinfarction

Stent choice in cardiogenic shock complicating acute myocardial infarction likely does not affect mortality or reinfarction Stent choice in cardiogenic shock complicating acute myocardial infarction likely does not affect mortality or reinfarction | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Stent choice in cardiogenic shock complicating acute myocardial infarction likely does not affect mortality or reinfarction Article Text

Evidence-Based Medicine (Requires free registration)2017

107. Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial.

Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial. 28025216 2016 12 27 2017 03 31 2055-6845 3 2 2017 Apr 01 European heart journal. Cardiovascular pharmacotherapy Eur Heart J Cardiovasc Pharmacother Hydroxychloroquine for the prevention of recurrent cardiovascular events in myocardial infarction patients: rationale and design of the OXI trial. 92-97 10.1093/ehjcvp/pvw035 Inflammation of the arterial (...) cholesterol levels and the risk of type II diabetes, and has also anti-platelet effects. The OXI trial is an event-driven trial that will randomize 2500 patients hospitalized for myocardial infarction (MI). Participants will receive active HCQ or placebo for at least 12 months, and until 350 CV events are confirmed. The primary trial endpoint is the composite of death, MI, hospitalization for unstable angina, urgent percutaneous coronary intervention, and urgent coronary artery bypass grafting. Secondary

European heart journal. Cardiovascular pharmacotherapy2016

108. The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of mi

The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of mi The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control (...) nitroprusside during primary percutaneous coronary intervention for ST-elevation myocardial infarction did not reduce infarct size and there was evidence of mid-term harm with adenosine. {{author}} {{($index , , , , , , , , , , & . Sheraz A Nazir, 1 Jamal N Khan, 1 Islam Z Mahmoud, 2 John P Greenwood, 3 Daniel J Blackman, 3 Vijay Kunadian, 4 Martin Been, 5 Keith R Abrams, 6 Robert Wilcox, 7 AA Jennifer Adgey, 8 Gerry P McCann, 1 Anthony H Gershlick, 1 ,* 1 Department of Cardiovascular Sciences, University

NIHR HTA programme2016

109. Association between cardiac rehabilitation participation and health status outcomes after acute myocardial infarction

Association between cardiac rehabilitation participation and health status outcomes after acute myocardial infarction 27760269 2018 11 13 2380-6591 1 9 2016 Dec 01 JAMA cardiology JAMA Cardiol Association Between Cardiac Rehabilitation Participation and Health Status Outcomes After Acute Myocardial Infarction. 980-988 10.1001/jamacardio.2016.3458 Cardiac rehabilitation (CR) improves survival after acute myocardial infarction (AMI), and referral to CR has been introduced as a performance measure (...) of high-quality care. The association of participation in CR with patients' health status (eg, quality of life, symptoms, and functional status) is poorly defined. To examine the association of participation in CR with health status outcomes after AMI. A retrospective cohort study was conducted of patients enrolled in 2 AMI registries: PREMIER, from January 1, 2003, to June 28, 2004, and TRIUMPH, from April 11, 2005, to December 31, 2008. The analytic cohort was restricted to 4929 patients with data

JAMA cardiology2016 Full Text: Link to full Text with Trip Pro

110. Strategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial Infarction

Strategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial Infarction 27933299 2018 11 13 2297-055X 3 2016 Frontiers in cardiovascular medicine Front Cardiovasc Med Strategy to Prime the Host and Cells to Augment Therapeutic Efficacy of Progenitor Cells for Patients with Myocardial Infarction. 46 Cell therapy in myocardial infarction (MI) is an innovative strategy that is regarded as a rescue therapy to repair the damaged myocardium (...) and to promote neovascularization for the ischemic border zone. Among several stem cell sources for this purpose, autologous progenitors from bone marrow or peripheral blood would be the most feasible and safest cell-source. Despite the theoretical benefit of cell therapy, this method is not widely adopted in the actual clinical practice due to its low therapeutic efficacy. Various methods have been used to augment the efficacy of cell therapy in MI, such as using different source of progenitors, genetic

Frontiers in cardiovascular medicine2016 Full Text: Link to full Text with Trip Pro

111. Aligning the planets: The role of nurses in the care of patients with non‐ST elevation myocardial infarction

Aligning the planets: The role of nurses in the care of patients with non‐ST elevation myocardial infarction 28078099 2018 11 13 2054-1058 4 1 2017 01 Nursing open Nurs Open Aligning the planets: The role of nurses in the care of patients with non-ST elevation myocardial infarction. 49-56 10.1002/nop2.69 Studies have shown variation in care for patients with non-ST elevation myocardial infarction (NSTEMI), including in the roles of specialist and advanced practice nurses in diagnosis (...) , treatment and coordination of care. The aim of this study was to describe the roles and responsibilities of specialist and advanced practice nurses in providing care for patients with NSTEMI. Secondary analysis of observational field notes and interviews from an ethnographic study of variation in care for NSTEMI patients in 10 UK hospitals conducted 2011-2012. Data were thematically analysed to identify key concepts and themes related to the roles of specialist nurses. Seven of 10 hospitals had roles

Nursing open2016 Full Text: Link to full Text with Trip Pro

112. The Use of Very Low Concentrations of High-sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test

The Use of Very Low Concentrations of High-sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test 27178492 2016 09 12 2017 03 24 1553-2712 23 9 2016 Sep Academic emergency medicine : official journal of the Society for Academic Emergency Medicine Acad Emerg Med The Use of Very Low Concentrations of High-sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test. 1004-13 10.1111/acem.13012 Recent single-center and retrospective (...) studies suggest that acute myocardial infarction (AMI) could be immediately excluded without serial sampling in patients with initial high-sensitivity cardiac troponin T (hs-cTnT) levels below the limit of detection (LoD) of the assay and no electrocardiogram (ECG) ischemia. We aimed to determine the external validity of those findings in a multicenter study at 12 sites in nine countries. TRAPID-AMI was a prospective diagnostic cohort study including patients with suspected cardiac chest pain within 6

EvidenceUpdates2016

113. Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial)

Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial) 27677387 2016 09 28 2017 04 27 2017 04 27 1879-1913 118 10 2016 Nov 15 The American journal of cardiology Am. J. Cardiol. Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial). 1442-1447 S0002 (...) -9149(16)31363-7 10.1016/j.amjcard.2016.08.004 The Thrombolysis in Myocardial Infarction (TIMI) risk score remains a robust prediction tool for short-term and midterm outcome in the patients with ST-elevation myocardial infarction (STEMI). However, the validity of this risk score in patients with STEMI with reduced left ventricular ejection fraction (LVEF) remains unclear. A total of 2,854 patients with STEMI with early coronary revascularization participating in the randomized EPHESUS (Epleronone

EvidenceUpdates2016

114. Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction

Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary Revascularization for Acute ST-Elevation Myocardial Infarction 27756477 2016 10 19 2017 05 01 2017 05 01 1879-1913 118 12 2016 Dec 15 The American journal of cardiology Am. J. Cardiol. Pooled Analysis Comparing the Efficacy of Intracoronary Versus Intravenous Abciximab in Smokers Versus Nonsmokers Undergoing Primary Percutaneous Coronary (...) Revascularization for Acute ST-Elevation Myocardial Infarction. 1798-1804 S0002-9149(16)31475-8 10.1016/j.amjcard.2016.08.068 Cigarette smokers with ST-segment elevation myocardial infarction (STEMI) may present different response to potent antithrombotic therapy compared to nonsmokers. We assessed the impact of smoking status and intracoronary abciximab in patients with STEMI undergoing primary percutaneous coronary intervention (PCI). We pooled data from 5 randomized trials comparing intracoronary versus

EvidenceUpdates2016

115. Association Between Depressive Disorders and Incident Acute Myocardial Infarction in Human Immunodeficiency Virus–Infected Adults: Veterans Aging Cohort Study

Association Between Depressive Disorders and Incident Acute Myocardial Infarction in Human Immunodeficiency Virus–Infected Adults: Veterans Aging Cohort Study 27557332 2018 09 17 2018 11 13 2380-6591 1 8 2016 11 01 JAMA cardiology JAMA Cardiol Association Between Depressive Disorders and Incident Acute Myocardial Infarction in Human Immunodeficiency Virus-Infected Adults: Veterans Aging Cohort Study. 929-937 10.1001/jamacardio.2016.2716 With the advent of highly effective antiretroviral (...) disorders are prospectively associated with incident acute myocardial infarction (AMI) in a large cohort of adults with HIV. Included in this cohort study were 26 144 HIV-infected veterans without CVD at baseline (1998-2003) participating in the US Department of Veterans Affairs Veterans Aging Cohort Study from April 1, 2003, through December 31, 2009. At baseline, 4853 veterans (19%) with major depressive disorder (MDD; International Classification of Diseases, Ninth Revision [ICD-9] codes 296.2

JAMA cardiology2016 Full Text: Link to full Text with Trip Pro

116. Life Expectancy after Myocardial Infarction, According to Hospital Performance.

Life Expectancy after Myocardial Infarction, According to Hospital Performance. BACKGROUND: Thirty-day risk-standardized mortality rates after acute myocardial infarction are commonly used to evaluate and compare hospital performance. However, it is not known whether differences among hospitals in the early survival of patients with acute myocardial infarction are associated with differences in long-term survival. METHODS: We analyzed data from the Cooperative Cardiovascular Project, a study (...) of Medicare beneficiaries who were hospitalized for acute myocardial infarction between 1994 and 1996 and who had 17 years of follow-up. We grouped hospitals into five strata that were based on case-mix severity. Within each case-mix stratum, we compared life expectancy among patients admitted to high-performing hospitals with life expectancy among patients admitted to low-performing hospitals. Hospital performance was defined by quintiles of 30-day risk-standardized mortality rates. Cox proportional

NEJM2016

117. Sexual activity and function in the year after an acute myocardial infarction (AMI) among younger women and men in the U.S. and Spain

Sexual activity and function in the year after an acute myocardial infarction (AMI) among younger women and men in the U.S. and Spain 27579897 2018 09 17 2018 11 13 2380-6591 1 7 2016 10 01 JAMA cardiology JAMA Cardiol Sexual Activity and Function in the Year After an Acute Myocardial Infarction Among Younger Women and Men in the United States and Spain. 754-764 10.1001/jamacardio.2016.2362 Most younger adults who experience an acute myocardial infarction (AMI) are sexually active before (...) the AMI, but little is known about sexual activity or sexual function after the event. To describe patterns of sexual activity and function and identify indicators of the probability of loss of sexual activity in the year after AMI. Data from the prospective, multicenter, longitudinal Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients study (conducted from August 21, 2008, to January 5, 2012) were assessed at baseline, 1 month, and 1 year. Participants were from US (n = 103

JAMA cardiology2016 Full Text: Link to full Text with Trip Pro

118. Opt-out Enrollment Increases Participation in a Remote Monitoring Intervention for Myocardial Infarction Patients

Opt-out Enrollment Increases Participation in a Remote Monitoring Intervention for Myocardial Infarction Patients 27603755 2018 09 17 2018 11 13 2380-6591 1 7 2016 10 01 JAMA cardiology JAMA Cardiol Participation Rates With Opt-out Enrollment in a Remote Monitoring Intervention for Patients With Myocardial Infarction. 847-848 10.1001/jamacardio.2016.2374 Mehta Shivan J SJ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia2Center for Health Incentives (...) Science. 2003 Nov 21;302(5649):1338-9 14631022 JAMA. 2004 Jun 9;291(22):2720-6 15187053 JAMA. 2007 Nov 28;298(20):2415-7 18042920 Humans Myocardial Infarction diagnosis Patient Participation Telemedicine 2016 10 21 6 0 2018 9 18 6 0 2016 9 8 6 0 ppublish 27603755 2549969 10.1001/jamacardio.2016.2374 PMC6140334 NIHMS988329

JAMA cardiology2016 Full Text: Link to full Text with Trip Pro

119. β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study. OBJECTIVE: To assess the association between early and prolonged β blocker treatment and mortality after acute myocardial infarction. DESIGN: Multicentre prospective cohort study. SETTING: Nationwide French registry of Acute ST- and non-ST-elevation Myocardial Infarction (FAST-MI) (at 223 centres) at the end of 2005. PARTICIPANTS: 2679 consecutive patients with acute (...) myocardial infarction and without heart failure or left ventricular dysfunction. MAIN OUTCOME MEASURES: Mortality was assessed at 30 days in relation to early use of β blockers (≤48 hours of admission), at one year in relation to discharge prescription, and at five years in relation to one year use. RESULTS: β blockers were used early in 77% (2050/2679) of patients, were prescribed at discharge in 80% (1783/2217), and were still being used in 89% (1230/1383) of those alive at one year. Thirty day mortality

BMJ2016 Full Text: Link to full Text with Trip Pro

120. An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay

An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay 27486143 2016 08 03 2017 01 06 1468-201X 103 2 2017 Jan 15 Heart (British Cardiac Society) Heart An algorithm for rule-in and rule-out of acute myocardial infarction using a novel troponin I assay. 125-131 10.1136/heartjnl-2016-309951 To derive and validate a hybrid algorithm for rule-out and rule-in of acute myocardial infarction based on measurements at presentation and after 2 hours

EvidenceUpdates2016